All Broad Institute articles
-
Business
Broad Institute backs central Crispr patent licensing platform
Key players submit 22 patents to pool, and urge other holders to create a one-stop shop for licensing deals
-
Business
Crispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other